Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Total Non-Current Liabilities came in at $1.6 billion in Q2 2026, up 16.06% on a YoY basis from $1.3 billion in Q2 2025, and up 6.29% quarter-over-quarter from $1.5 billion in Q1 2026.

Analysis

Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Total Non-Current Liabilities for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities rose 16.06% year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (up 16.06% YoY), and the FY2025 full-year result was $1.5 billion, up 18.35% from the prior year.
  • Total Non-Current Liabilities climbed to $1.6 billion in Q2 2026 per MEDP's latest filing, from $1.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.6 billion in Q2 2026 and bottomed at $722.1 million in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2024.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 68.68% in 2022, then retreated 2.17% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $943.4 million in 2022, then gained by 13.38% to $1.1 billion in 2023, then advanced by 15.23% to $1.2 billion in 2024, then increased by 18.35% to $1.5 billion in 2025, then increased by 7.2% to $1.6 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.6 billion, $1.5 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 22.94 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.56 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 6.94 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 4.24 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 2.15 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 30.49 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 553.39 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 28.62 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.56 Bn
Mar 31, 2026 1.47 Bn
Dec 31, 2025 1.46 Bn
Sep 30, 2025 1.40 Bn
Jun 30, 2025 1.35 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.23 Bn
Sep 30, 2024 1.17 Bn
Jun 30, 2024 1.13 Bn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 1.07 Bn
Sep 30, 2023 992.69 Mn
Jun 30, 2023 992.93 Mn
Mar 31, 2023 1.03 Bn
Dec 31, 2022 943.41 Mn
Sep 30, 2022 960.98 Mn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 722.11 Mn
Dec 31, 2021 689.26 Mn
Sep 30, 2021 663.00 Mn